Telehealth interventions in the context of the COVID-19 pandemic: Protocol for a scoping review
DOI:
https://doi.org/10.1590/SciELOPreprints.353Keywords:
COVID-19, Telehealth, Telemedicine, TechnologiesResumo
CONTEXT AND OBJECTIVE: The current health crisis due to COVID-19 is forcing us to profoundly rethink our social organizations and practices in health. While there is no effective treatment for the virus, staying home and social isolation are the control measures recommended by health authorities. The aim of this study is to perform a scoping review in order to summarize the current evidence in telehealth for COVID-19. METHODS: This study is a protocol to describe the rationale, hypothesis and planned methods of our scoping review. We will include randomized controlled trials (RCTs), observational cohort studies, case-control studies, cross-sectional studies, qualitative studies, and/or case series that describe telehealth interventions applied or developed to respond to COVID-19. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS - LILACS, and Scopus. We will include studies performed since December 2019 with no language restrictions. We will use the Risk of Bias tool and the Newcastle-Ottawa Scale to perform the critical appraisal of included studies. We will assess the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Downloads
Métricas
Postado
Como Citar
Série
Copyright (c) 2020 Maria Eduarda dos Santos Puga, Felipe Sebastião de Assis Reis, Keilla Martins Milby, Ana Carolina Pereira Nunes Pinto, César Ramos Rocha-Filho, Aline Pereira da Rocha, Nelson Carvas Junior, Vinicius Tassoni Civile, Rodolfo Rodrigo Pereira Santos, Gabriel Sodré Ramalho, Giulia Fernandes Moça Trevisani, Laura Jantsch Ferla, Maria Eduarda dos Santos Puga, Alvaro Nagib Atallah, Virgínia Fernandes Moça Trevisani
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.